Mapping and ablation of ventricular tachycardia with the aid of a non-contact mapping system

R J Schilling1, N S Peters, D W Davies

  • 1St Mary's Hospital and Imperial College School of Medicine, London, UK. r.schilling@ic.ac.uk

Insights

A novel non-contact mapping system safely treats ventricular tachycardia (VT) with low recurrence rates. This technology aids catheter ablation for coronary heart disease patients, offering a potential cure for VT.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Technology

Background:

  • Conventional treatments for ventricular tachycardia (VT) in coronary heart disease (CHD) are often palliative.
  • Catheter ablation for VT has been limited by difficulties in mapping complex VT substrates.
  • Existing mapping techniques struggle to precisely identify the electrical circuits responsible for VT.

Purpose of the Study:

  • To evaluate a new non-contact mapping system for identifying VT substrates.
  • To assess the efficacy and safety of catheter ablation guided by this novel technology.
  • To determine if this system can facilitate curative treatment for VT.

Main Methods:

  • A non-contact mapping system, including a multielectrode array catheter and computer mapping, was used in 24 patients with VT.
  • Patients included those with structural heart disease and those with normal ventricles experiencing fascicular or left ventricular ectopic tachycardia.
  • Radiofrequency ablation was performed targeting identified diastolic activation sites.

Main Results:

  • The non-contact system identified VT exit sites in 80/81 morphologies and complete circuits in 17.
  • Successful ablation was achieved in 77% of radiofrequency applications targeting diastolic activation.
  • At a mean follow-up of 1.5 years, 14 patients experienced no VT recurrence, with a low rate of target VT recurrence.

Conclusions:

  • The non-contact mapping system is safe and effective for mapping and ablating hemodynamically stable VT.
  • This technology is associated with low VT recurrence rates.
  • Further investigation is needed to confirm its efficacy in hemodynamically unstable VT patients.
Abstract